CorMedix (CRMD) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for CorMedix (CRMD) over the last 7 years, with Q3 2025 value amounting to $1.26.
- CorMedix's EPS (Weighted Average and Diluted) rose 262000.0% to $1.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.08, marking a year-over-year increase of 38888.89%. This contributed to the annual value of -$0.3 for FY2024, which is 6653.17% up from last year.
- As of Q3 2025, CorMedix's EPS (Weighted Average and Diluted) stood at $1.26, which was up 262000.0% from $0.28 recorded in Q2 2025.
- Over the past 5 years, CorMedix's EPS (Weighted Average and Diluted) peaked at $1.26 during Q3 2025, and registered a low of -$0.25 during Q1 2024.
- Its 5-year average for EPS (Weighted Average and Diluted) is $0.06, with a median of -$0.05 in 2024.
- As far as peak fluctuations go, CorMedix's EPS (Weighted Average and Diluted) crashed by 23095.17% in 2023, and later soared by 262000.0% in 2025.
- CorMedix's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.21 in 2021, then grew by 1.46% to -$0.2 in 2022, then grew by 16.6% to -$0.17 in 2023, then surged by 234.53% to $0.23 in 2024, then soared by 450.92% to $1.26 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $1.26 for Q3 2025, versus $0.28 for Q2 2025 and $0.3 for Q1 2025.